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The naïve CD4+ T-cell compartment is considered essential to guarantee immune com-
petence throughout life. Its replenishment with naïve cells with broad diverse receptor 
repertoire, albeit with reduced self-reactivity, is ensured by the thymus. Nevertheless, 
cumulative data support a major requirement of post-thymic proliferation both for the 
establishment of the human peripheral naïve compartment during the accelerated 
somatic growth of childhood, as well as for its lifelong maintenance. Additionally, a 
dynamic equilibrium is operating at the cell level to fine-tune the T-cell receptor threshold 
to activation and survival cues, in order to counteract the continuous naïve cell loss by 
death or conversion into memory/effector cells. The main players in these processes 
are low-affinity self-peptide/MHC and cytokines, particularly IL-7. Moreover, although 
naïve CD4+ T-cells are usually seen as a homogeneous population regarding stage of 
maturation and cell differentiation, increasing evidence points to a variety of phenotypic 
and functional subsets with distinct homeostatic requirements. The paradigm of cells 
committed to a distinct lineage in the thymus are the naïve regulatory T-cells, but other 
functional subpopulations have been identified based on their time span after thymic 
egress, phenotypic markers, such as CD31, or cytokine production, namely IL-8. 
Understanding the regulation of these processes is of utmost importance to promote 
immune reconstitution in several clinical settings, namely transplantation, persistent 
infections, and aging. In this mini review, we provide an overview of the mechanisms 
underlying human naïve CD4+ T-cell homeostasis, combining clinical data, experimental 
studies, and modeling approaches.
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inTRODUCTiOn AnD AiM
The thymus provides a unique microenvironment to support the differentiation of hematopoi-
etic progenitors into T-cells with a diverse repertoire of T-cell receptors (TCR), albeit with low 
self-reactivity (1). After thymus egression, the expression of the chemokine receptor CCR7 and 
L-selectin (CD62L) enables the naïve T-cells to patrol the body, through a continuous recirculation 
between the blood and secondary lymphoid organs (SLO) (2). The naïve compartment represents, 
therefore, the lifelong reservoir of T-cells able to mount specific responses to new antigens and to 
replenish the pool of memory-effector T-cells (3, 4). In addition to thymic output, several rounds of 
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post-thymic proliferation in SLO are considered necessary to fill 
the peripheral naïve T-cell compartment of a growing child (5–9). 
Moreover, its maintenance throughout life requires a dynamic 
equilibrium between thymic output and peripheral homeostatic 
proliferation and survival, in order to counteract the naïve cell 
loss through death or conversion into memory/effector cells 
(3, 4). The understanding of the fine-tuning of these processes 
is of utmost importance to ensure immune competence and to 
promote immune reconstitution in many clinical settings, namely 
transplantation, persistent infections, and aging.
We review here the homeostasis of human naïve T-cells, 
focusing on the CD4+ population given its pivotal role in immune 
response orchestration. Data from clinical settings, experimental 
studies, and modeling approaches were summarized to address 
the establishment of the naïve compartment, and the relative 
contribution of thymus and peripheral mechanisms to ensure the 
maintenance of naïve CD4+ T-cells throughout life. We further 
outline the cumulative evidence pointing to age-dependent 
maturation processes in the periphery that may alter the cell 
threshold to homeostatic cues (2, 10–14). Finally, the existence 
of phenotypic/functional naïve CD4+ T-cell subpopulations with 
distinct homeostasis is reviewed (13, 15–18), with a particular 
focus on thymic-derived regulatory T-cells (naïve-Tregs) that 
given their high self-reactivity are considered essential to prevent 
autoimmunity (19, 20). This suppressive lineage, defined by 
FOXP3 expression, has recently been shown to rely on unique 
homeostatic requirements (19, 21).
eSTABLiSHMenT OF THe nAÏve CD4+ 
T-CeLL COMPARTMenT
The human thymus was shown to be active from very early in 
embryonic life, with reports of progenitor colonization of the 
thymic primordium by the eighth week of gestation and of mature 
T-cells featuring an already diverse TCR repertoire by the end 
of first trimester (22–24). Human T-cell development is a tightly 
controlled multistep process [reviewed in Ref. (1)], that is out of 
the scope of this review. αβ T-cell diversity depends on random 
TCR rearrangements and assembly of β- and α-chains, as well as 
on selection processes (1, 25). Life or death decisions are mainly 
dictated by the strength of TCR signaling upon interaction with 
peptide/MHC complexes, ultimately resulting in generation 
of CD4 or CD8 single-positive (SP) cells, based on MHC-II 
or MHC-I restriction, respectively (1, 25–27). Thymocytes 
expressing high-affinity TCR for self-peptide/MHC complexes 
are deleted by apoptosis, a negative selection process critical for 
self-tolerance, as attested by the multiorgan autoimmune disease 
associated with autoimmune regulator (AIRE) gene mutations 
that impair the expression of peripheral self-peptides by thymic 
epithelial cells (28, 29). Of note, self-peptide low-affinity interac-
tions are later important for the peripheral homeostasis of the 
naïve compartment, by providing tonic signals that promote cell 
survival and low-level homeostatic proliferation (26).
The ultimate αβTCR diversity has been estimated to be as large 
as 1015 (26). It is worth emphasizing that the available tools to 
evaluate TCR diversity have significant limitations: spectratyping, 
which is based on length distribution of the most variable TCR 
region, poorly discriminates between loss of TCR specificities and 
biased clonal expansion (30, 31); and although next generation 
sequence (NGS) is a promising approach, the current algorithms 
still need improvements to fully account all variables inherent to 
the biology of TCR generation (25, 32, 33).
The thymus remains active until at least the sixth decade of life 
(34), as attested by de novo T-cell production in several clinical 
lymphopenic conditions, namely HIV/AIDS, hematopoietic stem 
cell transplantation (HSCT), and chemotherapy (35–38). Some 
authors claimed that thymic output peaks in first year of life and 
subsequently declines at annual rates of ~3% until 35–45 years 
of age, and ~1% thereafter, while others reported that the output 
of naïve T-cells only starts to decline in early adulthood (39, 40). 
This heterogeneity is, at least in part, related to differences in 
the methodological approaches used, namely histology versus 
measurement of thymic output by T-cell receptor excision circle 
(TREC) quantification (8, 39–43).
The DNA excised during β- and α-chain rearrangements 
results in several types of TRECs (44–47). sjTRECs, generated 
during the α-chain edition and containing signal joint (sj) 
sequence, have been broadly used to evaluate thymic activity 
(34). This PCR-based assay performed in circulating lymphocytes 
is also used in neonatal screening of major T-cell defects (48). 
TREC levels are influenced by peripheral events, namely cell 
proliferation and redistribution, or alterations in cell survival (41, 
49). Therefore, total sjTRECs/microliter levels represent a better 
estimate of thymic output than sjTREC quantification within a 
given subpopulation, which is manifestly influenced by post-
thymic proliferation (41, 49, 50). In line with this, the sj/βTREC 
ratio is considered a more accurate measurement of thymic 
activity, although the quantification of the TRECs generated dur-
ing earliest TCRβ locus rearrangements is technically complex, 
precluding its generalized applicability (51). Since TRECs are 
not duplicated during mitosis, and are therefore diluted out with 
each cellular division (44, 52), the sj/βTREC ratio provides a good 
measurement of the proliferation occurring between the β and α 
gene rearrangement during T-cell development, a direct correlate 
of thymic output (41, 51, 53).
It has also been suggested that some thymocytes may egress 
the thymus before switching from CD45RO to CD45RA, and 
only acquire the typical CD45RA+ naïve phenotype in the periph-
ery (54), which has implications for correctly estimating thymic 
output and rate of recent thymic emigrant (RTE) incorporation 
in the naïve T-cell pool. Moreover, there are no clear markers 
to identify RTEs, since while thymocytes express high levels of 
CD31 molecule at thymus egress, CD31bright cells may persist in 
circulation (55–57), and not all RTEs express protein tyrosine 
kinase 7 (PTK7), the other suggested marker (16, 58).
Both thymic epithelial cell development defects, namely 
DiGeorge syndrome and FOXN1 deficiency, and defects of hemat-
opoietic progenitors have severe clinical impact, which illustrates 
the non-redundant thymic contribution for the establishment 
of T-cell compartment (59, 60). Studies on primary immuno-
deficiency (61, 62), and on the immunological reconstitution 
achieved by the appropriate correction of these defects with HSCT 
(63), gene therapy (64–66), or thymus transplantation (67, 68), 
have been instrumental to better understand T-cell development. 
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As an illustrative example of the knowledge that can be gathered 
from these clinical cases, we showed that the activity of thymus 
explants, evaluated by sj/βTREC ratio, drastically diminished 
3 years post-thymic transplantation in a case of athymia due to 
FOXN1 deficiency (68). Nevertheless, this period was apparently 
sufficient to establish a sustained naïve T-cell compartment with 
a diverse TCR repertoire (68, 69).
THYMiC veRSUS PeRiPHeRAL 
COnTRiBUTiOn FOR nAÏve CD4+ 
T-CeLL MAinTenAnCe
The thymus also contributes to the maintenance of naïve CD4+ 
T-cell compartment, as demonstrated by the marked contraction 
observed in individuals submitted to complete thymectomy in 
early infancy due to corrective cardiac surgery [reviewed in Ref. 
(70)]. However, the thymus ability to adjust its output to periph-
eral requirements is still controversial, despite reports of thymic 
rebound in lymphopenic clinical settings (37, 71–75).
The dynamics of naïve T-cell compartment is also constrained 
by pressure to memory-effector differentiation (3). It has been 
suggested that naïve CD4+ T-cells may adjust their threshold for 
TCR activation with the length of time in circulation since thymus 
export (2, 8, 76) and with the aging of the individual (14, 77, 78).
Of note, in spite of the continuous environmental antigenic 
stimulation and the age-associated reduction in thymic output, 
the size of the human naïve T-cell pool features only a slight 
decline throughout adulthood (34, 55, 79, 80). Moreover, while 
sjTREC levels within CD4+ T-cells decrease 50–100 times with 
age (34, 75), the absolute numbers of naïve CD4+ T-cells decline 
only by a factor of 2–3 (79, 80). Therefore, thymic output per se 
is insufficient to guarantee the size of the human naïve CD4+ 
T-cell compartment, and a major contribution of post-thymic cell 
proliferation is required, as supported by in silico models (5–9, 81, 
82). In contrast, the naïve T-cell pool in mice is almost entirely 
maintained by thymic output (5), emphasizing the significant 
differences in T-cell development and homeostasis between the 
two species (2, 5, 83).
Naïve CD4+ T-cells feature low levels of proliferation 
while maintaining their naïve phenotype, as demonstrated 
by studies using in  vivo incorporation of deuterated water or 
Bromodeoxyuridine (BrdU) (7, 84, 85). It remains unclear 
whether naïve cell turnover changes with age (8, 77, 86, 87), as 
well as with the time span since thymic egress (2, 8, 76). The 
main proliferative cues appear to be low-affinity peptide/MHC 
interactions and cytokines, mainly IL-7, a γ-chain (γC) cytokine 
produced by stromal cells in SLO (56, 88–96). Experimental stud-
ies support that the low-affinity peptides, presented by MHC-II 
in a non-immunogenic fashion, are mainly self-antigens possibly 
related to those displayed in the thymus (97–99). In this scenario, 
naïve CD4+ T-cell proliferation could be viewed as a peripheral 
selection process, in which the repertoire of CD4+ T-cells is 
restricted by low-affinity self-peptides. Conversely, cytokines are 
thought to induce homeostatic proliferative responses without 
the bias of TCR specificity, and, thus, being vital to preserve broad 
diversity (100).
IL-7 signaling [reviewed in Ref. (101)] is strictly modulated 
by the expression of the α-chain of its receptor (IL-7Rα, CD127). 
IL-7 itself (102, 103), other γC-cytokines (102), and TCR 
stimulation (88, 103, 104) down-modulate IL-7Rα expression, 
which is upregulated in the absence of its cognate cytokine (102, 
103). In adults, this cytokine was shown to preferentially drive 
the proliferation of CD31+ naïve CD4+ T-cells, while sustaining 
the expression of CD31 in a PI3K-dependent manner (21, 57). 
Conversely, the IL-7-driven upregulation of the antiapoptotic 
molecule Bcl-2 was shown to occur irrespectively of CD31 expres-
sion and to be independent of the PI3K pathway (21, 57, 105). 
Interestingly, CD31 engagement inhibits TCR-mediated signal 
transduction via the immune-receptor tyrosine-based inhibi-
tory motifs (ITIMs) present in its cytoplasmic domain, raising 
the hypothesis that CD31 expression hampers TCR triggering, 
and thus favors the cytokine-driven homeostatic proliferation 
of CD31+ cells (56, 94, 106). On the other hand, TCR activa-
tion and cell division result in loss of CD31 expression (107). 
Therefore, the CD31− naïve subset has been proposed to result 
and be maintained by TCR triggering with low-affinity antigens 
(13, 94). Accordingly, CD31− naïve CD4+ T-cells express higher 
levels of the antiapoptotic BFL1/A1 than their CD31+ counter-
parts, a marker specifically induced by TCR signaling (94, 108, 
109). As a  result, the CD31− subset proliferation is thought to 
cause TCR repertoire contraction, in contrast to the expected 
maintenance of diversity upon IL-7 driven proliferation of the 
CD31+ naïve CD4+ T-cell subset (94, 110).
Accordingly, the therapeutic use of human recombinant IL-7 
was shown to induce preferential expansion of naïve CD4+ T-cells 
with a diverse TCR repertoire in several lymphopenia settings, 
namely HIV/AIDS (111, 112) and oncology (113, 114). The 
sjTREC content within CD31+ naïve CD4+ T-cells was reported 
to decrease following IL-7 administration in humans, supporting 
a significant degree of proliferation (114).
The maintenance of the naïve T-cell pool also depends on 
survival signals. During recirculation through SLO, naïve T-cells 
encounter IL-7, self-peptide/MHC complexes, and CCR7 ligands, 
all of which cooperate to produce homeostatic survival signals, 
namely upregulation of Bcl-2 (89, 115, 116). The relevance of cell 
survival pathways is further supported by the progressive loss of 
naïve CD4+ T-cells in association with defective Bcl-2 expres-
sion in patients with MST1 deficiency (117). An increase in the 
peripheral survival of naïve CD4+ T-cells in the elderly has been 
predicted by in  silico models, in agreement with experimental 
data in mice (118).
nAÏve CD4+ T-CeLL HeTeROGeneiTY
Naïve CD4+ T-cells are usually seen as a homogeneous population 
regarding stage of maturation and cell differentiation, although 
their phenotypic and functional variety is increasingly recognized 
(13, 15, 16, 18, 19). Next, we overview the main factors contribut-
ing to this heterogeneity, as well as the principal subpopulations 
identified. The paradigm of a naïve CD4+ T-cell population com-
mitted to a distinct lineage in the thymus is the naïve-Treg subset 
(19, 119), reviewed in the next section.
FiGURe 1 | Comparison of human naïve regulatory and conventional CD4+ T-cells.
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At thymus egress, naïve CD4+ T-cells feature unique pheno-
typic and functional properties (2, 13, 16, 76, 120). Moreover, 
in agreement with studies using manipulated murine models, 
the cell-intrinsic properties in terms of turnover, survival, and 
threshold for TCR activation is also modulated by prolonged 
time span in circulation (2, 8, 10–12, 121). It is possible that 
naïve CD4+ T-cells acquire properties before and/or after leaving 
the thymus that will impact on their differentiation into distinct 
memory-effector subsets (122).
Work from our lab and others identified two subsets within 
the naïve CD4+ T-cell compartment with distinct proliferative 
histories defined by the expression of CD31, which are main-
tained throughout life by different homeostatic mechanisms 
(13, 56, 57, 94). As discussed above, the proliferation/survival 
of the CD31+ subset, which includes the RTEs, is mainly 
driven by IL-7, whereas CD31− cells proliferate in response 
to TCR stimulation by low-affinity self-peptide/MHC (13, 56, 
57, 94). The CD31+ subset features a higher sjTREC content 
and telomere length than the CD31−, which has experienced 
more rounds of post-thymic proliferation (13, 56, 57, 94). The 
proportion of CD31+ cells within the naïve CD4+ compartment 
of human cord blood is up to 90–95% (56). Both absolute 
numbers and frequency of the CD31+ subset in peripheral 
blood decrease with aging, in parallel with the decline in their 
sjTREC content (13, 55, 56, 94, 123). In contrast, the counts of 
the CD31− subset remain relatively constant throughout adult 
life despite thymic involution, leading to a progressive increase 
in the relative proportion of CD31− within total naïve CD4+ 
T-cells with aging (13, 55, 94, 123).
In fact, age is the obvious determinant of naïve T-cell biol-
ogy, impacting both on thymic activity and on SLO microen-
vironment where peripheral homeostatic mechanisms operate 
(43,  124). The functional properties of naïve CD4+ T-cells 
change along infancy, with a clear trend to differentiation into 
a Th2 profile of cytokine production in early life (125,  126). 
Additionally, thymic-generated functional populations that 
are hardly found beyond the first decade of life have been 
described with a yet unclear role in immunity, as illustrated by 
the IL-8-producing subset (15, 18).
Finally, the human naïve CD4+ T-cell compartment has been 
recently shown to include a small population of memory cells 
(<1%), as attested by rapid interferon-γ production upon TCR 
stimulation, which could be identified by the expression of Fas 
(CD95) and β-chain of the IL-2 receptor (CD122), in the absence 
of CD45RO (17, 18). These so-called memory-stem cells are 
generated during primary immune responses and are considered 
a reservoir for the memory pool, in line with their unique ability 
to self-renew through still unclear mechanisms (17).
THe UniQUeneSS OF THe nAÏve 
ReGULATORY CD4+ T-CeLL 
COMPARTMenT
The subpopulation defined by FOXP3 expression is a hallmark 
of naïve CD4+ T-cell heterogeneity (19, 119). It is noteworthy 
that thymus removal early in infancy during corrective cardiac 
surgery was not associated with significant contraction of Foxp3+ 
naïve-Treg compartment (21, 127). Moreover, other clinical set-
tings known to impact on thymic output and leading to conven-
tional naïve CD4+ T-cell loss, namely HIV-1 infection, have been 
shown to feature preserved naïve-Tregs (128, 129). Altogether, as 
illustrated in Figure 1, these data support no thymic dependency 
and the existence of robust homeostatic peripheral mechanisms 
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that ensure the maintenance of the naïve-Treg compartment, 
even in extreme clinical settings.
The preservation of naïve-Tregs in thymectomized and HIV-
infected individuals was shown to be associated with increased 
turnover, as assessed by the cell cycling marker Ki-67 (21, 128). 
Moreover, in healthy subjects naïve-Tregs feature much higher 
rates of turnover than conventional naïve CD4+ T-cells, question-
ing the extent of niche sharing and competition for resources 
between these two naïve subsets (19, 21). Of note, matched blood 
and tonsil samples obtained from children submitted to routine 
tonsillectomy revealed higher frequency of cycling naïve-Tregs 
in the tonsils, with a larger fold-increase than in the conventional 
naïve CD4+ T-cell compartment (21).
T-cell receptor-affinity is thought to determine thymic Treg 
commitment, contributing to generate a repertoire skewed toward 
self-recognition (130–133). However, it has been shown that the 
high-affinity for self-peptides promotes their rapid differentiation 
into memory-Tregs upon TCR stimulation (19, 134–136), point-
ing to cytokines as important drivers of naïve-Treg homeostatic 
proliferation (21, 131).
Naïve-Tregs are known to express the α-chain of the IL-2 
receptor (CD25), although at lower levels than memory-Tregs, 
and to similarly express reduced levels of IL-7Rα (19). Several 
studies have addressed the impact of IL-7 on other Treg subsets, 
both in human and mouse, with heterogeneous results (137–141). 
Our in vitro studies revealed that IL-7 induced PI3K-dependent 
FiGURe 2 | naïve CD4+ T-cell steady-state homeostasis: main open questions.
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Altogether, these data support thymic-independent mainte-
nance of the naïve-Treg compartment (Figure 1), stressing the 
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COnCLUDinG ReMARKS
The accelerated somatic growth and overexposure to new antigens 
in infancy is expected to significantly impact on size and diversity 
of the naïve CD4+ T-cell compartment, although longitudinal 
data are limited (146). Pediatric studies are currently facilitated 
by the decrease in sample size allowed by recent NGS and flow-
cytometry advances (147, 148). These studies will ultimately 
provide a comprehensive understanding of the establishment 
and maturation of the naïve CD4+ T-cell compartment of unique 
value for vaccination, persistent infections, and immune reconsti-
tution clinical settings. Figure 2 outlines the main open questions 
discussed in this brief review, as well as the perspectives opened 
by recent methodological developments. Understanding the 
mechanisms underlying human naïve CD4+ T-cell homeostasis is 
ultimately critical to ensure immune competence throughout life.
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